Jammu Journal

The Global Clinical Diagnostics Market is expected to grow at a CAGR of 7.02% by 2028, estimates DelveInsight | Abbott, BD, bioMérieux , Bio-Rad Laboratories, Inc., Danaher Corp, Siemens AG, Hologic

 Breaking News
  • No posts were found

The Global Clinical Diagnostics Market is expected to grow at a CAGR of 7.02% by 2028, estimates DelveInsight | Abbott, BD, bioMérieux , Bio-Rad Laboratories, Inc., Danaher Corp, Siemens AG, Hologic

June 02
20:55 2023
The Global Clinical Diagnostics Market is expected to grow at a CAGR of 7.02% by 2028, estimates DelveInsight | Abbott, BD, bioMérieux , Bio-Rad Laboratories, Inc., Danaher Corp, Siemens AG, Hologic
Clinical Diagnostics Market

(New York, USA) DelveInsight’s Clinical Diagnostics Market Insights report provides the current and forecast market analysis, individual leading clinical diagnostics companies’ market shares, challenges, clinical diagnostics market drivers, barriers, and trends, and key clinical diagnostics companies in the market.

 

To read more about the latest highlights related to the clinical diagnostics market, get a snapshot of the key highlights entailed in the Global Clinical Diagnostics Market Forecast

 

Some facts of the Clinical Diagnostics Market Report

  • Leading clinical diagnostics companies working in the market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG, Hologic, Inc., Qiagen NV, Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Inc., BioReference Laboratories, Laboratory Corporation of America® Holdings, DiaSorin, PerkinElmer Inc., FUJIFILM Corporation, and others.
  • According to DelveInsight, North America is anticipated to dominate the global clinical diagnostics market during the forecast period. 
  • In October 2022, ixlayer, a digital diagnostics company, announced that it would manufacture CVS Health’s branded at-home sample collection kits.
  • In October 2022, Daye, has completed a USD 11.5 million funding round and announced the launch of its vaginal microbiome screening tests that can detect infections and pathogens linked to STIs and vaginal infections, as well as fertility, pregnancy, and IVF complications, making at-home vaginal health testing more accurate, comfortable and convenient.
  • On July 2022, Novacy experts in clinical diagnostics received approval for their product EXSIG™ COVID-19 direct test in the UK under CTDA legislation. 

 

Clinical Diagnostics Overview

Clinical Diagnosis (Dx) is the identification and confirmation of a disease or disorder, or exposure to xenobiotics, to explain the patient’s clinical manifestations. It is also used to assess an individual’s health (routine health checkup), the functioning of any organ or associated metabolic process (such as the extent of damage caused to an organ due to disease or injury and improvement in organ function due to treatment), and to distinguish one disease from another, particularly when similar manifestations are associated with multiple diseases or comorbid conditions occur.

 

Request for sample report @ https://www.delveinsight.com/sample-request/clinical-diagnostics-market

 

Clinical Diagnostics Market Insights

The global clinical diagnostics market is studied geographically for North America, Europe, Asia-Pacific, and the Rest of the World. North America currently leads the global market in terms of revenue share and is expected to maintain that position during the forecasted period. This dominance is due to the region’s growing government initiatives promoting the wider adoption of point-of-care clinical diagnosis methods in addition to traditional ones. Furthermore, companies expanding laboratory testing by launching new products are expected to boost clinical diagnostics growth during the forecasted period by increasing the clinical diagnostic market in various countries (2023–2028).

 

To know more about the factors driving the market growth in the clinical diagnostics market @ https://www.delveinsight.com/sample-request/clinical-diagnostics-market

 

Clinical Diagnostics Market Dynamics

The clinical diagnostics market is currently gaining traction due to an increase in the cases of various chronic disorders such as cardiovascular disease, diabetes, cancer, and others. Furthermore, rising cancer cases worldwide are expected to increase the demand for clinical diagnosis. Early cancer detection improves the chances of better treatment by focusing on detecting symptomatic patients as soon as possible.

Furthermore, the increase in infectious diseases such as COVID-19, bacterial diseases, and fungal diseases, among others, is expected to increase demand for clinical diagnosis globally, thereby increasing the market during the forecasted period.

The approval of various diagnostic kits for detecting COVID-19 infection boosted the clinical diagnostics market during the pandemic.

 

Get a sneak peek at the clinical diagnostics market dynamics @ https://www.delveinsight.com/sample-request/clinical-diagnostics-market

 

Clinical Diagnostics Market Assessment

  • Coverage: Global
  • Study Period: 2020–2028
  • Base Year: 2022
  • Market CAGR: 7.02%
  • Clinical Diagnostics Market Size in 2021: USD 70.11 Billion
  • Key Clinical Diagnostics Companies: Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG, Hologic, Inc., Qiagen NV, Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Inc., BioReference Laboratories, Laboratory Corporation of America® Holdings, DiaSorin, PerkinElmer Inc., FUJIFILM Corporation, among others
  • Clinical Diagnostics Market Segmentation
    • Market Segmentation By Type: Product Type (Instruments, Kits & Reagents), Services
    • Market Segmentation By Test: Complete Blood Count, Metabolic Panel, Lipid Panel, Cancer Testing Panel, Liver Panel, Infectious Disease Testing, Others
    • Market Segmentation By End User: Hospitals, Pathology Labs, Clinics, And Others
    • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

 

Which MedTech key players in the clinical diagnostics market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/sample-request/clinical-diagnostics-market

 

Table of Contents 

1. Report Introduction

2. Executive summary

3. Clinical Diagnostics Regulatory and Patent Analysis

4. Key Factors Analysis

5. Porter’s Five Forces Analysis

6. COVID-19 Impact Analysis on Clinical Diagnostics Market

7. Clinical Diagnostics Market Layout

8. Global Clinical Diagnostics Company Share Analysis – Key 3-5 Companies

9. Clinical Diagnostics Market Company and Product Profiles

10. Project Approach

11. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting-services

Categories